Liontrust has appointed, Mandy Donald as an independent non-executive director on the firm's board, effective 1 August 2019.
The appointment is subject to regulatory approval. Donald will also become chairman of the Audit & Risk Committee on 20 September 2019.
Donald has board experience in both complex organisations and early stage environments, and brings a background of strategic planning and operational management to the company. She has spent 18 years with EY before steering her focus towards the growth of new companies, serving on the boards of a diverse range of start-up businesses.
She is a trustee of The Institute of Cancer Research, where Donald also chair of the Audit Committee, she is also a non-executive director and chair of the Audit Committee of Punter Southall Group.